KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Assets (2016 - 2025)

Rigel Pharmaceuticals (RIGL) has 15 years of Return on Assets data on record, last reported at 0.97% in Q4 2025.

  • For Q4 2025, Return on Assets rose 86.0% year-over-year to 0.97%; the TTM value through Dec 2025 reached 0.97%, up 86.0%, while the annual FY2025 figure was 1.08%, 96.0% up from the prior year.
  • Return on Assets reached 0.97% in Q4 2025 per RIGL's latest filing, up from 0.5% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.97% in Q4 2025 and bottomed at 0.68% in Q3 2022.
  • Average Return on Assets over 5 years is 0.08%, with a median of 0.11% recorded in 2021.
  • Peak YoY movement for Return on Assets: tumbled -60bps in 2022, then soared 86bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.1% in 2021, then tumbled by -363bps to 0.47% in 2022, then skyrocketed by 54bps to 0.22% in 2023, then skyrocketed by 153bps to 0.12% in 2024, then skyrocketed by 742bps to 0.97% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.97% in Q4 2025, 0.5% in Q3 2025, and 0.51% in Q2 2025.